Study of a new treatment given before mastectomy and immediate breast reconstruction
Part of Skin clinical trials.
This study tests a new treatment called BLOOM43, given before surgery, in women having a mastectomy (breast removal) with immediate breast reconstruction. The treatment aims to improve the success of the reconstruction by preparing the breast tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 18 or older.
- You are having a skin-sparing or nipple-sparing mastectomy (breast removal) and immediate breast reconstruction (breast rebuilt at the same time).
- You are not having a delayed (two-stage) reconstruction or a simple mastectomy or lumpectomy.
- You do not have inflammatory breast cancer, ulcerated breast tumours, or T4 breast cancer.
- You do not have open wounds, infection, or inflammation on the breast skin.
- You do not have a cardiac pacemaker, defibrillator, or other implantable electronic device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special “pulsed rinse” technique during implant-based breast reconstruction improves care during surgery. If you’re having immediate expander placement at the time of mastectomy, you may be eligible to try this approach under research oversight.
This study looks at how women feel after having a robotic nipple-sparing mastectomy with immediate implant reconstruction. It focuses on their well-being and satisfaction after surgery.
This trial uses a special imaging technique to check blood flow in the skin during mastectomy with immediate breast reconstruction. The goal is to see if this imaging can predict which part of the skin might have healing problems, helping doctors make better decisions during surgery.
This study compares different ways of doing mastectomy (breast removal) and immediate or later breast reconstruction, with or without robotic assistance. The goal is to see which approach gives the best results for patients.
This trial tests a product called Plexaa, which is applied before surgery to help prepare the skin and improve healing. It is for transgender or non-binary people having a specific type of mastectomy (breast removal) for gender affirmation.
This study is looking at how radiotherapy affects women who have immediate breast reconstruction after mastectomy. The goal is to understand the changes and improve future care. Participants will have 3D imaging and answer questionnaires.
Hear when a new Skin Necrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.